Clinical Policy Bulletin: Ultrasound for Pregnancy
Number: 0199
Policy
Aetna considers ultrasounds not medically necessary if done solely to determine the fetal sex, or to provide parents with a view and photograph of the fetus.
A fetal ultrasound with detailed anatomic examination is considered medically necessary to evaluate the fetus for amniotic band syndrome (also known as amniotic constriction band syndrome), or if there are known or suspected fetal anatomic abnormalities, including anatomic abnormalities due to genetic conditions (see attached ICD-9 coding). More than one detailed ultrasound fetal anatomic examination per pregnancy per practice is considered experimental and investigational, as there is inadequate evidence of the clinical utility of multiple serial detailed fetal anatomic ultrasound examinations during pregnancy.
Detailed ultrasound fetal anatomic examination is considered experimental and investigational for all other indications including routine evaluation of pregnant women who smoke or abuse cannabis. There is inadequate evidence of the clinical utility of detailed ultrasound fetal anatomic examination for indications other than evaluation of suspected fetal anatomic abnormalities. Detailed ultrasound fetal anatomic examination is not considered medically necessary for routine screening of normal pregnancy.
Aetna considers three-dimensional (3D) and four-dimensional (4D) fetal ultrasounds experimental and investigational because of a lack of evidence that 3D and 4D ultrasounds alter management over standard two-dimensional (2D) ultrasounds such that clinical outcomes are improved.
This policy is based in part on The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin on Ultrasonography in Pregnancy and guidelines from the Society for Maternal-Fetal Medicine (SMFM).
Ultrasonography in pregnancy should be performed only when there is a valid medical indication. ACOG (2008) stated, "The use of either two-dimensional or three-dimensional ultrasonography only to view the fetus, obtain a picture of the fetus, or determine the fetal sex without a medical indication is inappropriate and contrary to responsible medical practice."
Indications for a first-trimester ultrasound (performed before 13 weeks and 6 days of gestation) include:
To confirm the presence of an intrauterine pregnancy
To evaluate a suspected ectopic pregnancy
To evaluate vaginal bleeding
To evaluate pelvic pain
To estimate gestational age
To diagnosis or evaluate multiple gestations
To confirm cardiac activity
As adjunct to chorionic villus sampling, embryo transfer, or localization and removal of an intrauterine device
To assess for certain fetal anomalies, such as anencephaly, in patients at high risk
To evaluate maternal pelvic or adnexal masses or uterine abnormalities
To screen for fetal aneuploidy
To evaluate suspected hydatidiform mole.
ACOG recommended that in the absence of specific indications, the optimal time for an obstetric ultrasound examination is between 18 - 20 weeks of gestation because anatomically complex organs, such as the fetal heart and brain, can be imaged with sufficient clarity to allow detection of many major malformations. This recommendation is based primarily on consensus and expert opinion (Level C). ACOG stated that it may be possible to document normal structures before 18 weeks of gestation but some structures can be difficult to visualize at that time because of fetal size, position, and movement; maternal abdominal scars; and increased maternal abdominal wall thickness. A second or third trimester ultrasound examination, however, may pose technical limitations for an anatomic evaluation due to suboptimal imaging, and when this occurs, ACOG recommended documentation of the technical limitation and that a follow-up examination may be helpful.
ACOG uses the terms "standard" (also called basic), "limited," and "specialized" (also called detailed) to describe various types of ultrasound examinations performed during the second or third trimesters.
Standard Examination
A standard ultrasound includes an evaluation of fetal presentation, amniotic fluid volume, cardiac activity, placental position, fetal biometry, and fetal number, plus an anatomic survey. A standard examination of fetal anatomy includes the following essential elements:
Head, face and neck (cerebellum, choroid plexus, cisterna magna, lateral cerebral ventricles, midline falx, cavum septi pellucidi, upper lip)
Chest (heart)
Abdomen (stomach, kidneys, bladder, umbilical cord insertion site into the fetal abdomen, umbilical cord vessel number)
Spine (cervical, thoracic, lumbar, and sacral spine)
Extremities (presence or absence of legs and arms)
Sex (medically indicated in low-risk pregnancies only for the evaluation of multiple gestations).
Limited Examination
A limited examination does not replace a standard examination and is performed when a specific question requires investigation (e.g., to confirm fetal heart activity in a patient experiencing vaginal bleeding or to establish fetal presentation during labor). A limited examination may be performed during the first trimester to evaluate interval growth, estimate amniotic fluid volume, evaluate the cervix, and assess the presence of cardiac activity.
Specialized Examination
A detailed or targeted anatomic examination is performed when an anomaly is suspected on the basis of history, laboratory abnormalities, or the results of either the limited or standard examination. Other specialized examinations might include fetal Doppler ultrasonography, biophysical profile, amniotic fluid assessment, fetal echocardiography, or additional biometric measurements. Specialized examinations are performed by an operator with experience and expertise in such ultrasonography who determines that components of the examination on a case-by-case basis.
Indications for a second and third trimester ultrasound include the following:
Estimation of gestational age
Evaluation of fetal growth
Evaluation of vaginal bleeding
Evaluation of cervical insufficiency
Evaluation of abdominal and pelvic pain
Determination of fetal presentation
Evaluation of suspected multiple gestation
Adjunct to amniocentesis or other procedure
Significant discrepancy between uterine size and clinical dates
Evaluation of pelvic mass
Examination of suspected hydatidiform mole
Adjunct to cervical cerclage placement
Evaluation of suspected ectopic pregnancy
Evaluation of suspected fetal death
Evaluation of suspected uterine abnormality
Evaluation for fetal well-being
Evaluation for premature rupture of membranes of premature labor
Evaluation for abnormal biochemical markers
Follow-up evaluation of a fetal anomaly
Follow-up evaluation of placental location for suspected placenta previa
Evaluation in those with a history of previous congenital anomaly
Evaluation of fetal condition in late registrants for prenatal care
To assess for findings that may increase the risk of aneuploidy
To screen for fetal anomalies.
The Society for Maternal-Fetal Medicine (SMFM) has stated that a fetal ultrasound with detailed anatomic examination (CPT 76811) is not necessary as a routine scan for all pregnancies (SMFM, 2004). Rather, this scan is necessary for a known or suspected fetal anatomic or genetic abnormality (i.e., previous anomalous fetus, abnormal scan during pregnancy, etc.). Thus, the SMFM has stated that the performance of this scan is expected to be rare outside of referral practices with special expertise in the identification of, and counseling about, fetal abnormalities (SMFM, 2004).
SMFM has also determined that no more than one fetal ultrasound with detailed anatomic examination is necessary per pregnancy, per practice, when medically necessary (SMFM, 2004). Once this detailed fetal anatomical exam is done, a second one should not be performed unless there are extenuating circumstances with a new diagnosis. The SMFM has stated that it is appropriate to repeat the detailed fetal anatomical ultrasound examination when a patient is seen by another maternal-fetal medicine specialist practice, for example, for a second opinion on a fetal anomaly, or if the patient is referred to a tertiary center in anticipation of delivering an anomalous fetus at a hospital with specialized neonatal capabilities.
A focused ultrasound assessment is sufficient for follow-up to provide a reexamination of a specific organ or system known or suspected to be abnormal, or when doing a focused assessment of fetal size by measuring the bi-parietal diameter, abdominal circumference, femur length, or other appropriate measurements (SMFM, 2004).
An ultrasound without detailed anatomic examination is appropriate for a fetal maternal evaluation of the number of fetuses, amniotic/chorionic sacs, survey of intracranial, spinal and abdominal anatomy, evaluation of a 4-chamber heart view, assessment of the umbilical cord insertion site, assessment of amniotic fluid volume, and evaluation of maternal adenexa when visible and appropriate (SMFM, 2004).
Amniotic band sequence refers to a highly variable spectrum of congenital anomalies that occur in association with amniotic bands. Amniotic banding affects approximately 1 in 1200 live births. It is also believed to be the cause of 178 in 10,000 miscarriages. Up to 50% of cases have other congenital anomalies including cleft lip, cleft palate, and clubfoot deformity. Hand and finger anomalies occur in up to 80%. The diagnosis is based upon the presence of characteristic structural findings on prenatal ultrasound or postnatal physical examination. The diagnosis should be suspected when limb amputations or atypical body wall or craniofacial defects are present, or when bands of amnion are seen crossing the gestational sac and adherent to the fetus.
Three-Dimensional and Four-Dimensional Ultrasound in Obstetrics
Three-dimensional (3D) ultrasound can furnish a 3-dimensional image of the fetus. To create a 3-dimensional image, a transducer takes a series of thin slices of the subject, and a computer translates these images and presents them in three dimensions.
Proponents of 3D ultrasound scanning have argued that volumetric measurements from 3D ultrasound scan are more accurate and that both clinicians and parents can better appreciate a certain abnormality with a 3D scan than a standard 2-dimensional (2D) scan. In addition, there is the possibility of increasing psychological bonding between the parents and the baby (Ji, et al., 2005).
In the diagnosis of congenital anomalies, there is evidence to suggest that smaller defects such as spina bifida, cleft lip and palate, and polydactyly may be more lucidly demonstrated with 3D ultrasound (Gonçalves, et al., 2005; Kurjak, et al., 2007). Other more subtle features such as low-set ears, facial dysmorphia or clubbling of feet may be better assessed, which has the potential to lead to more effective diagnoses of chromosomal abnormalities.
In addition, the use of 3D technology can reduce scanning time while maintaining adequate visualization of the fetus in obstetrical ultrasound (Benacerraf, et al., 2005; Benacerraf, et al., 2006).
More recently, 4-dimensional (4D) or dynamic 3D scanners have come on the market, with the attraction of being able to look at fetal movements. These have also been referred to as "reassurance scans" or "entertainment scans." Proponents argue that 4D scans may have an important catalytic effect for mothers to bond to their babies before birth. However, the impact of 4D scans on diagnosis and management of fetal abnormalities is unknown.
Three-dimensional ultrasound appears to have been useful in research on fetal embryology. However, there is no evidence that the results of 3D ultrasound alters clinical management over standard 2D ultrasound such that clinical outcomes are improved. Whether 3D ultrasound will provide unique, clinically relevant information remains to be seen.
Current guidelines on ultrasonography in pregnancy from the American College of Obstetricians and Gynecologists (2008) state: "The technical advantages of 3-dimensional ultrasonography include its ability to acquire and manipulate an infinite number of planes and to display ultrasound planes traditionally inaccessible by 2-dimensional ultrasonography. Despite these technical advantages, proof of a clinical advantage of 3-dimensional ultrasonography in prenatal diagnosis in general is still lacking. Potential areas of promise include fetal facial anomalies, neural tube defects, and skeletal malformations where 3-dimensional ultrasonography may be helpful in diagnosis as an adjunct to, but not a replacement for, 2-dimensional ultrasonography. Until clinical evidence shows a clear advantage to conventional 2-dimensional ultrasonography, 3-dimensional ultrasonography is not considered a required modality at this time."
CPT Codes / HCPCS Codes / ICD-9 Codes
Routine fetal ultrasounds:
CPT codes covered if selection criteria are met:
76801
+ 76802
76805
+ 76810
76815
76816
ICD-9 codes covered (for routine fetal ultrasounds) if selection criteria are met:
640.00 - 676.94
Complications of pregnancy and childbirth
V22.0 - V23.9
Supervision of pregnancy
V28.3
Encounter for routine screening for malformation using ultrasonics
V28.4
Screening for fetal growth retardation using ultrasonics
Detailed fetal ultrasounds:
CPT codes covered if selection criteria are met:
76811
+ 76812
ICD-9 codes covered (for detailed fetal ultrasounds) if selection criteria are met:
647.43
Malaria complicating pregnancy, antepartum condition or complication
647.63
Other viral diseases complicating pregnancy, antepartum condition or complication
647.83
Other specified infectious and parasitic diseases complicating pregnancy, antepartum condition or complication
648.03
Diabetes mellitus complicating pregnancy, antepartum condition or complication
648.33
Drug dependence complicating pregnancy, antepartum condition or complication
648.53
Congenital cardiovascular disorders complicating pregnancy, antepartum condition or complication
651.03
Twin pregnancy, antepartum condition or complication
651.13
Triplet pregnancy, antepartum condition or complication
651.23
Quadruplet pregnancy, antepartum condition or complication
651.33
Twin pregnancy with fetal loss and retention of one fetus, antepartum condition or complication
651.43
Triplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication
651.53
Quadruplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication
653.63
Hydrocephalic fetus causing disproportion complicating pregnancy, antepartum condition or complication
653.73
Other fetal abnormality causing disproportion complicating pregnancy, antepartum condition or complication
655.03
Central nervous system malformation in fetus complicating pregnancy, antepartum condition or complication
655.13
Chromosomal abnormality in fetus complicating pregnancy, antepartum condition or complication
655.23
Hereditary disease in family possibly affecting fetus complicating pregnancy, antepartum condition or complication
655.33
Suspected damage to fetus from viral disease in the mother complicating pregnancy, antepartum condition or complication
655.43
Suspected damage to fetus from other disease in the mother complicating pregnancy, antepartum condition or complication
655.53
Suspected damage to fetus from drugs, complicating pregnancy, antepartum condition or complication
655.63
Suspected damage to fetus from radiation, complicating pregnancy, antepartum condition or complication
655.83
Other known or suspected fetal abnormality, not elsewhere classified, complicating pregnancy, antepartum condition or complication
655.93
Unspecified known or suspected fetal abnormality affecting management of mother, antepartum condition or complication
656.13
Rhesus isoimmunization complicating pregnancy, antepartum condition or complication
656.23
Isoimmunization from other and unspecified blood-group incompatibility, antepartum condition or complication
656.53
Poor fetal growth complicating pregnancy, antepartum condition or complication
657.03
Polyhydramnios complicating pregnancy antepartum condition or complication
658.03
Oligohydramnios complicating pregnancy, antepartum condition or complication
659.53
Elderly primigravida complicating pregnancy, antepartum condition or complication
659.63
Elderly multigravida complicating pregnancy, antepartum condition or complication
659.73
Abnormality in fetal heart rate or rhythm, antepartum condition or complication
663.83
Other umbilical cord complications, antepartum condition or complication
665.93
Unspecified obstetrical trauma, antepartum condition or complication
793.6
Nonspecific abnormal findings on radiological and other examinations of abdominal area, including retroperitoneum
793.9
Other nonspecific abnormal findings on radiological and other examinations of body structure
V23.81
Supervision of high-risk pregnancy of elderly primigravida
V23.82
Supervision of high-risk pregnancy of elderly multigravida
V28.2
Other antenatal screening based on amniocentesis
ICD-9 codes not covered for indications listed in the CPB (not all-inclusive):
305.20 - 305.23
Cannabis abuse
Three-dimensional (3D) and four-dimensional (4D) fetal ultrasounds:
There are no specific codes for 3D and 4D fetal ultrasound
CPT codes not covered for indications listed in the CPB:
76376
76377
The above policy is based on the following references:
Bofill JA, Sharp GH. Obstetric sonography. Who to scan, when to scan, and by whom. Obstet Gynecol Clin North Am. 1998;25(3):465-478.
Wagner RK, Calhoun BC. The routine obstetric ultrasound examination. Obstet Gynecol Clin North Am. 1998;25(3):451-463.
Dubbins PA. Screening for chromosomal abnormality. Semin Ultrasound CT MR. 1998;19(4):310-317.
Garmel SH, D'Alton ME. Diagnostic ultrasound in pregnancy: An overview. Semin Perinatol. 1994;18(3):117-132.
Seeds JW. The routine or screening obstetrical ultrasound examination. Clin Obstet Gynecol. 1996;39(4):814-830.
Gebauer C, Lowe N. The biophysical profile: Antepartal assessment of fetal well-being. J Obstet Gynecol Neonatal Nursing. 1993;22(2):115-123.
Salvesen K. Routine ultrasound scanning in pregnancy. BMJ. 1993;307(6911):1064.
Rodney WM, Deutchman ME, Hartman, KJ, et al. Obstetric ultrasound by family physicians. J Family Practice. 1992;34(2):186-200.
Evans MI, Chervenak FA, Eden RD. Report of the Council on Scientific Affairs of the American Medical Association: Ultrasound evaluation of the fetus. Fetal Diagnosis Therapy. 1991;6(3-4):132-147.
American College of Obstetricians and Gynecologists (ACOG). Multiple gestation. ACOG Technical Bulletin No.131. Washington, DC: ACOG; August 1989.
American Academy of Pediatrics (AAP) and American College of Obstetricians and Gynecologists (ACOG). Guidelines for Perinatal Care. 4th ed. Elk Grove Village, IL: AAP; August 1997.
American College of Obstetricians and Gynecologists (ACOG), Committee on Obstetric Practice. Guidelines for diagnostic imaging during pregnancy. ACOG Committee Opinion No. 158. Washington, DC: ACOG; September 1995.
American College of Obstetricians and Gynecologists (ACOG), Committee on Practice Bulletins -- Obstetrics. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. Obstet Gynecol. 2001;97(5 Pt 1):suppl 1-12.
Barnett SB, Maulik D; International Perinatal Doppler Society. Guidelines and recommendations for safe use of Doppler ultrasound in perinatal applications. J Matern Fetal Med. 2001;10(2):75-84.
Jurkovic D. Three-dimensional ultrasound in gynecology: A critical evaluation. Ultrasound Obstet Gynecol. 2002;19(2):109-117.
Davies G, Wilson RD, Desilets V, et al. Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus. J Obstet Gynaecol Can. 2003;25(2):145-148, 149-152.
Bricker L, Garcia J, Henderson J, et al. Ultrasound screening in pregnancy: A systematic review of the clinical effectiveness, cost-effectiveness and women's views. Health Technol Assess. 2000;4(16):i-vi, 1-193.
Demianczuk NN, Van Den Hof MC, Farquharson D, et al. The use of first trimester ultrasound. Obstet Gynaecol Can. 2003;25(10):864-875.
Institute for Clinical Systems Improvement (ICSI). Prenatal ultrasound as a screening test. ICSI Technology Assessment Report No. 16. Bloomington, MN: ICSI; updated October 2002. Available at: http://www.icsi.org. Accessed March 31, 2004.
Hata T, Kanenishi K, Inubashiri E, et al. Three-dimensional sonographic features of placental abnormalities. Gynecol Obstet Invest. 2004;57(2):61-65.
American College of Obstetricians and Gynecologists. ACOG Committee Opinion #296: First-trimester screening for fetal aneuploidy. Obstet Gynecol. 2004;104(1):215-217.
American College of Obstetricians and Gynecologists (ACOG Committee on Ethics. ACOG Committee Opinion. Number 297, August 2004. Nonmedical use of obstetric ultrasonography. Obstet Gynecol. 2004;104(2):423-424.
American College of Obstetricians and Gynecologists (ACOG), Committee on Practice Bulletins -- Obstetrics. Ultrasonography in pregnancy. ACOG Practice Bulletin No. 58. Washington, DC: ACOG; December 2004.
Morin L, Van den Hof MC; Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. Ultrasound evaluation of first trimester pregnancy complications. Number 161, June 2005. Int J Gynaecol Obstet. 2006;93(1):77-81.
Goncalves LF, Lee W, Espinoza J, Romero R. Three- and 4-dimensional ultrasound in obstetric practice: does it help? J Ultrasound Med. 2005;24(12):1599-1624.
Kurjak A, Miskovic B, Andonotopo W, et al. How useful is 3D and 4D ultrasound in perinatal medicine? J Perinat Med. 2007;35(1):10-27.
Ji EK, Pretorius DH, Newton R, et al. Effects of ultrasound on maternal-fetal bonding: A comparison of two- and three-dimensional imaging. Ultrasound Obstet Gynecol. 2005;25(5):473-477.
Benacerraf BR, Shipp TD, Bromley D. How sonographic tomography will change the face of obstetric sonography: A pilot study. J Ultrasound Med. 2005;24(3):371-378.
Benacerraf BR, Shipp TD, Bromley B. Improving the efficiency of gynecologic sonography with 3-dimensional volumes: A pilot study. J Ultrasound Med. 2006;25(2):165-171.
Benacerraf BR, Shipp TD, Bromley B. Three-dimensional US of the fetus: Volume imaging. Radiology. 2006;238(3):988-996.
American College of Obstetricians and Gynecologists (ACOG) Committee on Health Care for Underdeserved Women; ACOG Committee on Obstetric Practice. ACOG committee opinion. Number 316, October 2005. Smoking cessation during pregnancy. Obstet Gynecol. 2005;106(4):883-888.
American College of Obstetricians and Gynecologists (ACOG), Committee on Practice Bulletins -- Obstetrics. Ultrasonography in pregnancy. ACOG Practice Bulletin No. 98. Washington, DC: ACOG; October 2008.
Copyright Aetna Inc. All rights reserved. Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.